Home / Health / Diabetes Drug Saves Thousands: New Hope for Patients
Diabetes Drug Saves Thousands: New Hope for Patients
10 Feb
Summary
- New diabetes drug reduces premature deaths by 24%.
- Study suggests 20,000 deaths could be prevented annually.
- Drugs protect heart and kidneys alongside blood sugar control.
A new class of SGLT-2 inhibitor medications for type 2 diabetes has demonstrated remarkable effectiveness, potentially preventing approximately 20,000 deaths each year in the UK. Research analyzed data from 60,000 individuals, revealing a 24% decrease in premature mortality over three years compared to other treatments.
These once-daily tablets, including canagliflozin and others, work by aiding the kidneys in glucose removal. This mechanism not only lowers blood sugar but also offers significant protection to the heart and kidneys, according to emerging evidence.
The National Institute for Health and Care Excellence (Nice) has endorsed these SGLT-2 inhibitors as a first-line treatment. This recommendation, supported by UCL and LSHTM experts, signifies a substantial evolution in diabetes management affecting millions across the UK.
